Related Experiment Video
Updated: Aug 25, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene
Amy Baldwin1, Lucia Pirisi, Kim E Creek
1Department of Pathology and Microbiology, University of South Carolina School of Medicine, Columbia, South Carolina 29208, USA.
Abstract:
Human papillomaviruses (HPVs) are present in virtually all cervical cancers. An important step in the development of malignant disease, including cervical cancer, involves a loss of sensitivity to transforming growth factor beta (TGF-beta). HPV type 16 (HPV16) early gene expression, including that of the E6 and E7 oncoprotein genes, is under the control of the upstream regulatory region (URR), and E6 and E7 expression in HPV16-immortalized human epithelial cells is inhibited at the transcriptional level by TGF-beta. While the URR contains a myriad of transcription factor binding sites, including seven binding sites for nuclear factor I (NFI), the specific sequences within the URR or the transcription factors responsible for TGF-beta modulation of the URR remain unknown. To identify potential transcription factors and binding sites involved in TGF-beta modulation of the URR, we performed DNase I footprint analysis on the HPV16 URR using nuclear extracts from TGF-beta-sensitive HPV16-immortalized human keratinocytes (HKc/HPV16) treated with and without TGF-beta. Differentially protected regions were found to be located around NFI binding sites. Electrophoretic mobility shift assays, using the NFI binding sites as probes, showed decreased binding upon TGF-beta treatment. This decrease in binding was not due to reduced NFI protein or NFI mRNA levels. Mutational analysis of individual and multiple NFI binding sites in the URR defined their role in TGF-beta sensitivity of the promoter. Overexpression of the NFI family members in HKc/HPV16 decreased the ability of TGF-beta to inhibit the URR. Since the oncoprotein Ski has been shown to interact with and increase the transcriptional activity of NFI and since cellular Ski levels are decreased by TGF-beta treatment, we explored the possibility that Ski may provide a link between TGF-beta signaling and NFI activity. Anti-NFI antibodies coimmunoprecipitated endogenous Ski in nuclear extracts from HKc/HPV16, confirming that NFI and Ski interact in these cells. Ski levels dramatically decreased upon TGF-beta treatment of HKc/HPV16, and overexpression of Ski eliminated the ability of TGF-beta to inhibit the URR. Based on these studies, we propose that TGF-beta inhibition of HPV16 early gene expression is mediated by a decrease in Ski levels, which in turn dramatically reduces NFI activity.
Insights
Transforming growth factor beta (TGF-beta) inhibits human papillomavirus type 16 (HPV16) early gene expression by reducing Ski protein levels, which decreases nuclear factor I (NFI) activity.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Human papillomaviruses (HPVs), particularly HPV type 16 (HPV16), are implicated in cervical cancer development.
- Loss of sensitivity to transforming growth factor beta (TGF-beta) is crucial for malignant progression.
- HPV16 early gene expression, controlled by the upstream regulatory region (URR), is normally inhibited by TGF-beta.
Purpose of the Study:
- To identify transcription factors and binding sites in the HPV16 URR involved in TGF-beta-mediated regulation.
- To elucidate the molecular mechanism by which TGF-beta inhibits HPV16 early gene expression.
Main Methods:
- DNase I footprinting and electrophoretic mobility shift assays (EMSA) on the HPV16 URR.
- Nuclear factor I (NFI) and Ski protein/mRNA level analysis.
- Mutational analysis of NFI binding sites within the URR.
- Co-immunoprecipitation assays to assess NFI-Ski interaction.
Main Results:
- TGF-beta treatment decreased NFI binding to its sites within the HPV16 URR, independent of NFI protein or mRNA levels.
- Mutations in NFI binding sites affected TGF-beta sensitivity.
- Overexpression of NFI family members reduced TGF-beta's inhibitory effect.
- TGF-beta treatment decreased cellular Ski levels, and Ski overexpression abrogated TGF-beta's inhibition.
- NFI and Ski were found to interact in HPV16-immortalized keratinocytes.
Conclusions:
- TGF-beta inhibits HPV16 early gene expression by reducing Ski protein levels.
- The decrease in Ski leads to reduced NFI activity.
- This Ski-NFI pathway is the mechanism by which TGF-beta modulates the HPV16 URR.
Related Concept Videos
TGF - β Signaling Pathway
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly

